Page 10 - Jamie Christensen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jamie christensen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jamie Christensen Today - Breaking & Trending Today

Mirati Therapeutics (NASDAQ:MRTX) Issues Earnings Results, Beats Estimates By $0.19 EPS

Mirati Therapeutics (NASDAQ:MRTX – Get Free Report) issued its quarterly earnings data on Tuesday. The biotechnology company reported ($3.04) earnings per share for the quarter, beating the consensus estimate of ($3.23) by $0.19, Briefing.com reports. The firm had revenue of $13.70 million for the quarter, compared to analyst estimates of $13.17 million. Mirati Therapeutics had […] ....

United States , Stifel Nicolaus , Laurie Stelzer , Jamie Christensen , Metlife Investment Management , Mirati Therapeutics Inc , Advisor Group Holdings Inc , Mirati Therapeutics Company Profile , Acadian Asset Management , Us Bancorp , Mirati Therapeutics , Get Free Report , Group Holdings , Financial Advisors , Asset Management , Mirati Therapeutics Daily , Nasdaq Mrtx ,

Mirati Therapeutics (NASDAQ:MRTX) Stock Price Up 6.5% After Analyst Upgrade

Mirati Therapeutics (NASDAQ:MRTX) Stock Price Up 6.5% After Analyst Upgrade
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United States , Jamie Christensen , Laurie Stelzer , Mirati Therapeutics Company Profile , Advisor Group Holdings Inc , Headlands Technologies , Quent Capital , Mirati Therapeutics Inc , Mirati Therapeutics , Get Free Report , Group Holdings , Captrust Financial Advisors , Financial Advisors , Mirati Therapeutics Daily ,

Mirati Therapeutics (NASDAQ:MRTX) Shares Gap Up Following Earnings Beat

Shares of Mirati Therapeutics, Inc. (NASDAQ:MRTX – Get Free Report) gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $27.80, but opened at $34.62. Mirati Therapeutics shares last traded at $36.49, with a volume of 2,594,846 shares traded. The biotechnology company reported […] ....

United States , Jamie Christensen , Laurie Stelzer , Stifel Nicolaus , International Biotechnology Trust , Century Group , Mirati Therapeutics Company Profile , Securities Exchange Commission , Swiss National Bank , Mirati Therapeutics Inc , Envestnet Asset Management Inc , Mirati Therapeutics , Get Free Report , Exchange Commission , National Bank , Biotechnology Trust , Envestnet Asset Management , Asset Management , Mirati Therapeutics Daily , Nasdaq Mrtx ,

Mirati Therapeutics (MRTX) Scheduled to Post Earnings on Tuesday

Mirati Therapeutics (MRTX) Scheduled to Post Earnings on Tuesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Jamie Christensen , Stifel Nicolaus , Laurie Stelzer , Corton Capital Inc , American Century Companies Inc , E Fund Management Co , Snowden Capital Advisors , Delphia United States Inc , Mirati Therapeutics Inc , Fund Management Co , Securities Exchange Commission , Mirati Therapeutics , Get Free Report , Therapeutics Stock Down , Exchange Commission , Fund Management , Capital Advisors , Century Companies , Delphia United States , Mirati Therapeutics Daily ,

Mirati Therapeutics (NASDAQ:MRTX) Earns Underperform Rating from Analysts at Scotiabank

Scotiabank began coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a research report released on Thursday morning, MarketBeat Ratings reports. The brokerage issued an underperform rating on the biotechnology company’s stock. MRTX has been the topic of several other reports. Stifel Nicolaus reduced their price objective on Mirati Therapeutics from $78.00 to […] ....

United States , Jamie Christensen , Laurie Stelzer , Stifel Nicolaus , Quent Capital , Mirati Therapeutics Company Profile , Securities Exchange Commission , Advisor Group Holdings Inc , Mirati Therapeutics Inc , Mirati Therapeutics , Free Report , Marketbeat Ratings , Get Free Report , Exchange Commission , Group Holdings , Financial Advisors , Neo Ivy Capital Management , Mirati Therapeutics Daily , Nasdaq Mrtx , Initiated Coverage ,